Literature DB >> 31058417

Positive margin rates and predictors in transoral robotic surgery after federal approval: A national quality study.

Jonathan Hanna1, Elliot Morse1, Philip R Brauer1, Benjamin Judson2, Saral Mehra2.   

Abstract

BACKGROUND: Purpose of the study is to assess nationwide margin performance in oropharynx transoral robotic surgery (TORS).
METHODS: Retrospective review of the National Cancer Database.
RESULTS: Two thousand six hundred sixty-one patients were included. The national positive margin rate (PMR) was 16.9%. High-volume facilities had a lower PMR than low-volume facilities (12.7% vs 21.9%; P < .001). Patients with disease of the tonsil had a lower PMR (15.7%) than base-of-the-tongue (18.2%; P = .14). PMR increased with T classification (T1 = 13.0%, T2 = 17.1%, T3 = 28.2%, T4a = 45.9%, T4b = 58.3%; P < .001). On multivariable regression, factors associated with margin status included only lymph-vascular invasion (1.63[1.13-2.36]; P = .01), high volume (0.57[0.36-0.92]; P = .005), and T classification (as compared to T1, T2: 1.50[1.03-2.18], T3: 3.11[1.77-5.46], T4a: 7.03[2.95-16.75], T4b: 6.72[1.26-35.93]; P < .001).
CONCLUSIONS: National PMR is 16.9%, substantially higher than reported in high-volume TORS centers. There is a linear association between positive margins and T classification, with T3 and T4 PMRs exceeding 28%. High-volume facilities are half as likely to yield positive margins compared to low-volume facilities. There was no association between human papilloma virus status, tumor subsite, or academic facility status and positive margins.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  oropharyngeal cancer; surgical margins; transoral robotic surgery

Mesh:

Year:  2019        PMID: 31058417     DOI: 10.1002/hed.25792

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Association of Intraoperative Frozen Section Controls With Improved Margin Assessment During Transoral Robotic Surgery for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.

Authors:  Alice C Yu; David D Afework; Jeffrey D Goldstein; Elliot Abemayor; Abie H Mendelsohn
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2022-09-22       Impact factor: 8.961

2.  Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.

Authors:  Jamie R Oliver; Michael J Persky; Binhuan Wang; Umamaheswar Duvvuri; Neil D Gross; Alec E Vaezi; Luc G T Morris; Babak Givi
Journal:  Cancer       Date:  2021-11-11       Impact factor: 6.921

Review 3.  Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma of the Tonsil versus Base of Tongue: A Systematic Review and Meta-Analysis.

Authors:  Nicolas S Poupore; Tiffany Chen; Shaun A Nguyen; Cherie-Ann O Nathan; Jason G Newman
Journal:  Cancers (Basel)       Date:  2022-08-08       Impact factor: 6.575

4.  The robotic-assisted extended "Sistrunk" approach for tumors of the upper aerodigestive tract with limited transoral access: First description of oncological and functional outcomes.

Authors:  Christian Simon; Avinash Beharry; Vinidh Paleri; Pascaline Dübi; Karma Lambercy; F Christopher Holsinger; Jelena Todic
Journal:  Head Neck       Date:  2022-06-02       Impact factor: 3.821

Review 5.  Value and Quality of Care in Head and Neck Oncology.

Authors:  Robert P Takes; Gyorgy B Halmos; John A Ridge; Paolo Bossi; Matthias A W Merkx; Alessandra Rinaldo; Alvaro Sanabria; Ludi E Smeele; Antti A Mäkitie; Alfio Ferlito
Journal:  Curr Oncol Rep       Date:  2020-07-10       Impact factor: 5.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.